Cabot Corporation
CBTNYSEMaterialsSpecialty Chemicals
As of Oct 15, 2026 close
- Market cap
- $3.92B
- P/E (TTM)
- 20.66
- Forward P/E
- 41.81
- Dividend yield
- 2.44%
- 52-week range
- $58.33$94.53
- Volume (live)
- -
- Avg. volume (3M)
- 398.40K
Cabot (CBT) Stock Price & Financial Analysis
Cabot Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $75.27 - $76.35 |
|---|---|
| 52-Week High | $94.53 |
| 52-Week Low | $58.33 |
| Open | $75.99 |
| Volume (last close) | 321.25K |
| Average Volume (3M) | 398.40K |
| Revenue (TTM) | 3.63B |
|---|---|
| Net Income (TTM) | 190.00M |
| Free Cash Flow (TTM) | 281.00M |
| EPS (TTM) | $3.61 |
| Profit Margin | 5.23% |
| Operating Margin | 13.79% |
| Return on Equity (ROE) | 10.96% |
| Debt to Equity | 0.73 |
| Annual Dividend | $1.85 |
|---|---|
| Dividend Yield | 2.44% |
| Payout Ratio | 51.10% |
| Last Dividend Ex-Date | Aug 28, 2026 |
| Market Cap | 3.92B |
|---|---|
| Shares Outstanding | 52.00M |
| P/E Ratio (TTM) | 20.66 |
| Forward P/E | 41.81 |
| Price to Sales (P/S) | 1.08 |
| Price to Book (P/B) | 2.26 |
| EV/EBITDA | 6.76 |
| 50-Day MA | $80.89 |
|---|---|
| 200-Day MA | $79.29 |
| 1-Year Change | +9.20% |
Source: Market prices and company fundamentals. Data as of Oct 15, 2026. Data sources and methodology
Cabot at a Glance
As of the Oct 15, 2026 close, Cabot (CBT) has a market capitalization of $3.92B. The stock trades at 20.7× trailing earnings, 41.8× forward earnings and 1.1× sales. Over the trailing twelve months it earned $190.00M on revenue of $3.63B (a 5.2% profit margin) and generated $281.00M of free cash flow. Revenue fell 4.7% year over year.
As of its latest reported balance sheet, it holds $250.00M in cash and securities against $1.27B of debt, a net debt position of $1.02B.
Cabot pays a quarterly dividend totaling $1.84 per share a year, a 2.44% yield at the Oct 15, 2026 close, with a 51% payout ratio and 14 consecutive years of dividend increases.
The share price is up 9.2% over the past year. At $75.48 (the Oct 15, 2026 close) it sits within its 52-week range of $58.33 to $94.53, below its 200-day moving average of $79.29.
Based on 5 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $87.33, 15.7% above the Oct 15, 2026 close.
Frequently Asked Questions About Cabot
What is the current stock price for CBT?
As of the Oct 15, 2026 close, CBT stock trades at $75.48. The 52-week range is $58.33–$94.53, with a day range of $75.27–$76.35.
What is the P/E ratio for CBT?
As of the Oct 15, 2026 close, Cabot's trailing twelve-month (TTM) P/E ratio is 20.7, meaning investors pay $20.7 for every $1 of annual earnings. The forward P/E is 41.8, reflecting analyst expectations for future earnings. Cabot operates in the Materials sector.
Does CBT pay dividends?
Yes, Cabot pays a 2.44% annual dividend yield as of the Oct 15, 2026 close ($1.84 per share a year). The trailing twelve-month payout ratio is 51.1%. The most recent ex-dividend date was August 28, 2026.
What do analysts recommend for CBT?
Based on ratings from 5 professional analysts over the last 90 days, the consensus for CBT is Buy. The average 12-month price target is $87.33, a 15.7% upside from the Oct 15, 2026 close of $75.48.
What is the market cap of CBT?
As of the Oct 15, 2026 close, Cabot's market capitalization is $3.92B, classifying it as a mid-cap company. Cabot operates in the Materials sector within the Specialty Chemicals industry.